X

Drug Profile

Research programme: pain therapeutics - Schering-Plough

Alternative Names: opioid like receptor 1 agonists; ORG 26383; ORG 27899; ORL-1 agonists

Latest Information Update: 26 Jan 2010

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Organon
Developer Schering-Plough
Class Benzimidazoles
Mechanism of Action Nociceptin receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

No development reported Pain; Sedation

Most Recent Events

19 Nov 2007 Organon has been acquired and merged into Schering-Plough
06 Sep 2004 Preclinical trials in Pain in Scotland (unspecified route)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com